Cellestia presented its poster at SOHC – Swiss Oncology and Hematology Congress

Cellestia presented at SOHC  in Zurich on 18-20 Nov 2021 “A novel CSL-NICD inhibitor for the treatment of NOTCH-driven T-cell acute lymphoblastic leukemia: a case report.” Medinger M, Junker T, Halter J, Heim D, Tzankov A, Bobadilla M, Vogl FD, Bauer M, Passweg J.

To read the poster please click here.

 

Cellestia’s new lab opening at Superlab, Lausanne

CB-103 has been granted an Orphan Designation for the treatment of Acute Lymphoblastic Leukaemia (ALL)